REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cenbiocli S.A. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Cenbiocli S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cenbiocli S.A. is an enterprise based in Ecuador. Its main office is in Cuenca. The enterprise operates in the Medical and Diagnostic Laboratories industry. It was established on January 03, 2007. Cenbiocli S.A. currently employs 16 (2023) people. From the latest financial highlights, Cenbiocli S.A. reported a net sales revenue drop of 17.1% in 2023. Over the same period, its total assets decreased by 15.21%.

Headquarters
Av 10 de Agosto, Torres del Yanuncay Bldg.
Cuenca; Azuay;

Contact Details: Purchase the Cenbiocli S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Cenbiocli S.A. report to view the information.
Outstanding Shares:
Purchase the Cenbiocli S.A. report to view the information.
Registered Capital:
Purchase the Cenbiocli S.A. report to view the information.
Incorporation Date:
January 03, 2007
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
5.4%
Purchase this report to view the information.
5.4%
Purchase this report to view the information.
5.4%
Purchase this report to view the information.
5.4%
Purchase this report to view the information.
5.4%
Company Performance
Financial values in the chart are available after Cenbiocli S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-17.1%▼
Total operating revenue
-18.79%▼
Operating profit (EBIT)
98.04%▲
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-15.21%▼
Total equity
-9.97%▼
Operating Profit Margin (ROS)
95.36%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.82%▼
Quick Ratio
1.97%▲
Cash Ratio
1.97%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo